Ethic Inc. Applied Therapeutics Inc. Transaction History
Ethic Inc.
- $5.89 Billion
- Q3 2025
A detailed history of Ethic Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Ethic Inc. holds 27,193 shares of APLT stock, worth $33,991. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,193
Previous 28,629
5.02%
Holding current value
$33,991
Previous $8,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$23.4 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$14.4 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$14.1 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$9.75 Million1.64% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$8.21 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $60M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...